iRay Technology Co., Ltd.

iRay Technology Co., Ltd. has demonstrated notable stock performance, achieving a significant gain on March 24, 2026. Over the past year, the company has outperformed the China Shanghai Composite index, despite facing recent challenges. Its financial metrics indicate a strong market capitalization and low debt levels.

iRay Technology Co. faced a challenging trading day on March 23, 2026, with a notable decline in stock value. Despite recent setbacks, the company has shown strong annual performance, significantly outperforming the China Shanghai Composite. However, it has reported negative results for three consecutive quarters, indicating ongoing difficulties.

iRay Technology Co., Ltd. saw its stock price decline significantly today, contrasting with the broader market. Despite a strong annual return, the company has reported negative results for three consecutive quarters, raising concerns about its growth potential amid falling profits and rising costs in the Pharmaceuticals & Biotechnology sector.

iRay Technology Co., Ltd. saw a significant stock decline today, contrasting with the broader market's performance. Despite recent gains and strong year-to-date returns, the company faces challenges, including consecutive quarterly losses and rising raw material costs, while maintaining a high price-to-earnings ratio in the Pharmaceuticals & Biotechnology sector.

iRay Technology Co. has experienced notable stock performance, gaining 4.38% on October 24, 2025, and reaching an intraday high of CNY 120.28. Despite a 27.8% decline in profits over the past year, the company has shown strong sales growth and impressive year-to-date returns.

iRay Technology Co., Ltd. faced a notable stock decline on October 13, 2025, amid challenges in the Pharmaceuticals & Biotechnology sector. Despite a strong year-to-date performance, the company reported a significant profit drop and maintains a high price-to-earnings ratio, reflecting its premium valuation amidst market volatility.

iRay Technology Co., Ltd. saw its stock price decline significantly today, contrasting with the broader market. Despite a strong annual return of over 61%, the company has faced challenges, including three consecutive quarters of negative results and a notable profit decline. Financial metrics indicate a high valuation and conservative leverage.